RXO, Inc.
NYSE:RXOTrucking
+$0.80 today
- Market cap
- $4.72B
- Beta
- 1.97
- P/E (TTM)
- -41.3
- EPS (TTM)
- -$0.62
Volume 3.64M
Average 2.33M
RXO Net Receivables
Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.
RXO, Inc.NYSE: RXO
Net Receivables · Q2 FY2026 · quarter ended Jun 2026
Net receivables falls 99.9% from a year ago
Net receivables stood at $1.44M at the end of Q2 FY2026, down 99.9% from a year earlier and down 99.9% from the prior quarter. Over 3 fiscal years it compounded at +11.6% a year.
Context
- Net receivables amounted to 41.7% of total assets at the end of Q2 FY2026, up 8.5 pp from a year earlier.
- Net receivables increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether net receivables keeps falling in the next quarterly balance sheet after a -99.9% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Net Receivables history
USD · from the balance sheet
- Latest · FY2025
- 1.25B USD
- Year-over-year change
- +2.0%
- 4-year CAGR
- +5.5%
| Period | Period end | Net Receivables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 1.25B | +2.0% |
| FY2024 | 2024-12-31 | 1.23B | +65.1% |
| FY2023 | 2023-12-31 | 743M | -17.4% |
| FY2022 | 2022-12-31 | 900M | -10.9% |
| FY2021 | 2021-12-31 | 1.01B | — |
Net Receivables vs competitors
How RXO compares with its peers on the latest reported figures
- RXO's Jun 2026 net receivables of $1.44M is the lowest of the 11 companies compared; the peer median is $248.95M.
- Its year-over-year change of -99.9% is the lowest of 11, against a peer median of +20.5%.
- Net receivables amounts to 41.7% of total assets for RXO, versus a peer median of 8.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jul 2026 | $1.48B | -10.6% | +7.1% | 26.4% | |
| Jun 2026 | $615.36M | +31.5% | +2.6% | 15.6% | |
TICTIC Solutions, Inc. | Jun 2026 | $585.02M | +127.1% | — | 13.6% |
| Jun 2026 | $335.3M | +8.6% | -16.4% | 7.1% | |
| Jun 2026 | $257.88M | +9.6% | +12.4% | 5.3% | |
| Jun 2026 | $240.02M | +2.7% | +10.9% | 9.6% | |
| Jun 2026 | $177.47M | -62.8% | +69.1% | 4.0% | |
| Sep 2026 | $113.53M | +272.5% | +145.6% | 5.1% | |
| Mar 2026 | $35.26M | +239.2% | +225.9% | 27.0% | |
| Mar 2026 | $3.83M | +156.0% | — | 0.4% | |
| Jun 2026 | $1.44M | -99.9% | +11.6% | 41.7% | |
| Peer median (excluding RXO) | $248.95M | +20.5% | +11.7% | 8.4% | |
Competitors are the stored peer set for RXO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
RXO, Inc.
NYSE:RXO
Intrinsic Alpha fair value
Locked
Current Price
$28.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.